UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~August~~October 254, 2006

VWR INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

~~Delaware~~DELAWARE (State or other jurisdiction of incorporation) 333-118658 (Commission File Number) 91-1319190 (I.R.S. Employer Identification No.)

1310 Goshen Parkway P.O. Box 2656 West Chester, PA 19380 (Address of principal executive offices, including zip code)

1310 Goshen Parkway
P.O. Box 2656
West Chester, PA	19380
(Address of principal executive offices)	(zip code)

(~~Registrant’s telephone number, including area code): (~~610) 431-1700

(Registrant’s telephone number, including area code)

None
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 57.0201 ~~DEPARTURE~~REGULATION OFFD ~~DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.~~DISCLOSURE

~~Axel~~On October ~~Ruckert~~4, ~~has~~2006, ~~resigned~~John ~~from~~Ballbach, ~~the~~President ~~Board~~and ofChief ~~Directors~~Executive Officer, and Jack Wyszomierski, Executive Vice President and Chief Financial Officer, of VWR International, Inc. ~~effective~~(“VWR”) ~~September~~will 22make a presentation at the Deutsche Bank Healthcare Conference. A copy of the presentation slides, ~~2006~~which will be discussed at that presentation, is attached hereto as Exhibit 99.1, accompanied by a Credit Agreement EBITDA reconciliation.

2Item 9.01 Financial Statements and Exhibits

~~SIGNATURES~~(d) Exhibits

~~Pursuant~~99.1 toSlide ~~the~~presentation ~~requirements of~~to ~~the~~be ~~Securities~~presented ~~Exchange~~at ~~Act~~Deutsche ofBank ~~1934,~~Healthcare ~~the~~Conference ~~registrant~~on ~~has~~October ~~duly~~4, ~~caused~~2006, ~~this report~~accompanied ~~to be signed on its behalf~~ by ~~the~~a ~~undersigned~~Credit ~~thereunto~~Agreement ~~duly~~EBITDA ~~authorized.~~ reconciliation

	VWR INTERNATIONAL, INC.
Date: August 25, 2006	By:	/s/ JACK L. WYSZOMIERSKI
		Name: Jack L. Wyszomierski
		Title: Executive Vice President and Chief Financial Officer

3SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VWR INTERNATIONAL, INC.

Date: October 4, 2006	By:	/s/ Jack L. Wyszomierski
		Name: Jack L. Wyszomierski
		Title: Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

Exhibit No.		Description

99.1		Slide presentation to be presented at Deutsche Bank Healthcare Conference on October 4, 2006, accompanied by a Credit Agreement EBITDA reconciliation.

Filing Compare · VWR International, LLC